• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The increasing burden of NAFLD fibrosis in the general population: Time to bridge the gap between hepatologists and primary care.

作者信息

van Asten Marloes, Verhaegh Pauline, Koek Ger, Verbeek Jef

机构信息

Division of Gastroenterology and Hepatology Department of Internal Medicine, Maastricht University Medical Center, Maastricht, Netherlands.

出版信息

Hepatology. 2017 Mar;65(3):1078. doi: 10.1002/hep.28940. Epub 2017 Jan 3.

DOI:10.1002/hep.28940
PMID:27862126
Abstract
摘要

相似文献

1
The increasing burden of NAFLD fibrosis in the general population: Time to bridge the gap between hepatologists and primary care.普通人群中非酒精性脂肪性肝病纤维化负担日益加重：是时候弥合肝病专家与初级保健之间的差距了。
Hepatology. 2017 Mar;65(3):1078. doi: 10.1002/hep.28940. Epub 2017 Jan 3.
2
Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis.基层医疗临床医生对非酒精性脂肪性肝病认识不足：对纤维化替代标志物的认识有限。
Intern Med J. 2018 Feb;48(2):144-151. doi: 10.1111/imj.13667.
3
Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?非酒精性脂肪性肝病与多囊卵巢综合征必然相关而非偶然相关的证据：一种新的肝-卵巢轴？
Endocrine. 2016 Feb;51(2):211-21. doi: 10.1007/s12020-015-0640-8. Epub 2015 May 30.
4
APPROACH TO THE PATIENT WITH NONALCOHOLIC FATTY LIVER DISEASE.非酒精性脂肪性肝病患者的诊疗方法
Lijec Vjesn. 2016 May;138(5-6):159-163.
5
The epidemiology of non-alcoholic fatty liver disease.非酒精性脂肪性肝病的流行病学。
Liver Int. 2017 Jan;37 Suppl 1:81-84. doi: 10.1111/liv.13299.
6
Real-life Perception and Practice Patterns of NAFLD/NASH in Romania: Results of a Survey Completed by 102 Board-certified Gastroenterologists.罗马尼亚非酒精性脂肪性肝病/非酒精性脂肪性肝炎的真实感知和实践模式：102 名经董事会认证的胃肠病学家完成的调查结果。
J Gastrointestin Liver Dis. 2016 Jun;25(2):183-9. doi: 10.15403/jgld.2014.1121.252.naf.
7
Putting non-alcoholic fatty liver disease on the radar for primary care physicians: how well are we doing?将非酒精性脂肪性肝病纳入初级保健医生的雷达范围：我们做得如何？
BMC Med. 2018 Aug 24;16(1):148. doi: 10.1186/s12916-018-1149-9.
8
Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution.非酒精性脂肪性肝病（NAFLD）患者的肝动脉阻力指数（HARI）与非酒精性脂肪性肝病纤维化评分：提示非酒精性脂肪性肝炎（NASH）进展的临界值
J Ultrasound. 2016 Mar 29;19(3):183-9. doi: 10.1007/s40477-016-0203-8. eCollection 2016 Sep.
9
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床流行病学和疾病负担。
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
10
Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.在初级保健中通过MRI和MRE对糖尿病患者进行非侵入性筛查以检测非酒精性脂肪性肝病和肝纤维化进展情况。
Aliment Pharmacol Ther. 2016 Jan;43(1):83-95. doi: 10.1111/apt.13405. Epub 2015 Sep 15.

引用本文的文献

1
Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022?普通人群中肝纤维化的筛查：2022年我们处于什么水平？
Diagnostics (Basel). 2022 Dec 28;13(1):91. doi: 10.3390/diagnostics13010091.
2
Using Telehealth for Diagnosis and Management of Non-Alcoholic Fatty Liver Disease.利用远程医疗进行非酒精性脂肪性肝病的诊断与管理。
Clin Liver Dis (Hoboken). 2022 Apr 29;19(4):171-175. doi: 10.1002/cld.1191. eCollection 2022 Apr.
3
Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?糖尿病中的非酒精性脂肪性肝病：何时转诊至肝病专家？
World J Diabetes. 2021 Sep 15;12(9):1479-1493. doi: 10.4239/wjd.v12.i9.1479.
4
Case-finding strategies in non-alcoholic fatty liver disease.非酒精性脂肪性肝病的病例发现策略
JHEP Rep. 2020 Dec 5;3(2):100219. doi: 10.1016/j.jhepr.2020.100219. eCollection 2021 Apr.
5
Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis - epidemiology, risk factors, clinical implications and treatment.非酒精性脂肪性肝炎患者的肝细胞癌——流行病学、危险因素、临床意义及治疗
Clin Exp Hepatol. 2020 Sep;6(3):170-175. doi: 10.5114/ceh.2020.99506. Epub 2020 Sep 30.
6
Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics.非酒精性脂肪性肝病：基层医疗与肝病科诊所之间的联系
Hepatol Commun. 2020 Feb 20;4(4):518-526. doi: 10.1002/hep4.1486. eCollection 2020 Apr.
7
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.非酒精性脂肪性肝病与急性心肌梗死和卒中发病风险的关系：来自 1800 万欧洲成年人匹配队列研究的结果。
BMJ. 2019 Oct 8;367:l5367. doi: 10.1136/bmj.l5367.
8
Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease.真实世界的数据揭示了非酒精性脂肪性肝病诊断方面的差距。
BMC Med. 2018 Aug 13;16(1):130. doi: 10.1186/s12916-018-1103-x.